Haemato

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2024, Haemato has already paid €0.04 in dividends. The last payout was in July 2024.

Financials

In the last year, Haemato had revenue of €248.14M and net profit of €8.19M

(EUR)	2022	YoY
Revenue	248.14M	12.95%
Gross profit	15.3M	29.67%
Net profit	8.19M	25.39%
EBITDA	12.21M	8.91%

Fundamentals

Metric	Value
Market capitalization	€111.5M
Number of shares	5.21M
52-week high/low	€28.00 - €17.40
Dividends	No
Beta	1.29
P/E ratio	13.63
PEG ratio	0.14
P/B ratio	0.76
P/S ratio	0.45

Company profile

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.